In addition, lncRNA growth arrest-specific 5 (lncGAS5) modulates NLRP3 expression in both in vivo and in vitro models of PD and upregulates NLRP3 via competing miR-223-3p [57]. This evidence concerns the gene NLRP3 and Parkinson disease.